Journal of Cardiac Failure
Volume 14, Issue 6 , Pages 445-452 , August 2008

Pioglitazone and Heart Failure: Results From a Controlled Study in Patients With Type 2 Diabetes Mellitus and Systolic Dysfunction

  • Thomas D. Giles, MD

      Affiliations

    • Tulane University School of Medicine, New Orleans, Louisiana
    • Corresponding Author InformationReprint requests: Thomas Giles, MD, Professor of Medicine, Tulane University School of Medicine, 109 Holly Drive, Metairie, LA 70005.
    • ,
  • Alan B. Miller, MD

      Affiliations

    • University of Florida Health Science Center, Jacksonville, Florida
    • ,
  • Uri Elkayam, MD

      Affiliations

    • University of Southern California Keck School of Medicine, Los Angeles, California
    • ,
  • Mondira Bhattacharya, MD

      Affiliations

    • Takeda Global Research & Development Center, Inc, Deerfield, Illinois
    • ,
  • Alfonso Perez, MD

      Affiliations

    • Takeda Global Research & Development Center, Inc, Deerfield, Illinois

Received 27 August 2007 ,Revised 22 January 2008 ,Accepted 5 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Sponsored and funded by Takeda Global Research & Development Center, Inc. Deerfield, Illinois.

 Partial data from this study have been published previously as congress abstracts (American College of Cardiology Scientific Session 2007 and European Society of Cardiology Congress 2007).

 Dr. Thomas Giles has received honoraria for speaking/consulting services and research grants from Takeda Pharmaceuticals; Dr. Allen Miller has received honoraria for speaking services from Takeda Pharmaceuticals and payment from GlaxoSmithKline for consulting services; Dr. Uri Elkayam has received honoraria for speaking/consulting services and research grants from Takeda Pharmaceuticals; Drs. Perez and Bhattacharyra are employees of Takeda Pharmaceuticals.

 Funded by Takeda Pharmaceuticals (Takeda Global Research & Development).

PII: S1071-9164(08)00060-2

doi: 10.1016/j.cardfail.2008.02.007

Journal of Cardiac Failure
Volume 14, Issue 6 , Pages 445-452 , August 2008

Article Tools

* Image Usage & Resolution